Editorial commentary: Searching for the sweet spot of cardioprotection in cancer treatment related cardiotoxicity: Who will benefit?

Affiliations

¹ UW Cardio-Oncology Program, Division of Cardiology, Department of Medicine, University of Washington, Seattle, WA, United States. Electronic address: rkcheng@uw.edu.
² UCLA Cardio-Oncology Program, Division of Cardiology, Department of Medicine, University of California at Los Angeles, Los Angeles, CA, United States.

Free article

Editorial

Richard K Cheng et al. Trends Cardiovasc Med. 2020 Jan.

Free article

. 2020 Jan;30(1):29-31.

doi: 10.1016/j.tcm.2019.02.003. Epub 2019 Feb 15.

¹ UW Cardio-Oncology Program, Division of Cardiology, Department of Medicine, University of Washington, Seattle, WA, United States. Electronic address: rkcheng@uw.edu.
² UCLA Cardio-Oncology Program, Division of Cardiology, Department of Medicine, University of California at Los Angeles, Los Angeles, CA, United States.

No abstract available

Keywords: Breast cancer; Cardio-oncology; Cardioprotection; Cardiotoxicity.

Comment on

Cardioprotective strategies to prevent breast cancer therapy-induced cardiotoxicity.
Padegimas A, Clasen S, Ky B. Padegimas A, et al. Trends Cardiovasc Med. 2020 Jan;30(1):22-28. doi: 10.1016/j.tcm.2019.01.006. Epub 2019 Jan 29. Trends Cardiovasc Med. 2020. PMID: 30745071 Free PMC article. Review.